Substance / Medication

Propylhexedrine

Overview

Active Ingredient
propylhexedrine
RxNorm CUI
8792

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Green and blue space exposure and non-communicable disease related hospitalizations: A systematic review.
Luque-García L, Muxika-Legorburu J, Mendia-Berasategui O et al. · Environ Res · 2024
PMID: 38157973Meta-Analysis
Respiratory dysfunction in degenerative cervical myelopathy: A systematic review.
Elliott Lorcan, Li Michael, Gharooni Aref-Ali et al. · J Clin Neurosci · 2024
PMID: 38237493Meta-Analysis
Respiratory dysfunction in persistent somatic symptoms: A systematic review of observational studies.
Niwa Saya, Fila-Pawłowska Karolina, Van den Bergh Omer et al. · J Psychosom Res · 2024
PMID: 38388305Meta-Analysis
Validity and reliability of outcome measures to assess dysfunctional breathing: a systematic review.
Mohan Vikram, Rathinam Chandrasekar, Yates Derick et al. · BMJ Open Respir Res · 2024
PMID: 38626928Meta-AnalysisFull text (PMC)
A comprehensive meta-analysis on safety outcomes reveals the novel potentials of SGLT2is, especially preventing respiratory diseases.
Cai YuJun, Zou HaiTao, Hu Rong et al. · Front Endocrinol (Lausanne) · 2024
PMID: 38742192Meta-AnalysisFull text (PMC)
A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA).
Martí Yasmina, Aponte Ribero Valerie, Batson Sarah et al. · J Neuromuscul Dis · 2024
PMID: 38943396Meta-AnalysisFull text (PMC)
Exposure to outdoor particulate matter and risk of respiratory diseases: a systematic review and meta-analysis.
Nakhjirgan Pegah, Kashani Homa, Kermani Majid · Environ Geochem Health · 2023
PMID: 38153542Meta-Analysis
Neurologic Deficits Following Oral Misuse of the Nasal Decongestant Propylhexedrine.
Horowitz Keahi M, Cassidy Emma, Temple Courtney · J Med Toxicol · 2024
PMID: 39103667Case ReportFull text (PMC)
Abuse, Toxicology and the Resurgence of Propylhexedrine: A Case Report and Review of Literature.
Teja Nikhil, Dodge Caroline P, Stanciu Cornel N · Cureus · 2020
PMID: 33178521Case ReportFull text (PMC)
A drug toxicity death involving propylhexedrine and mitragynine.
Holler Justin M, Vorce Shawn P, McDonough-Bender Pamela C et al. · J Anal Toxicol · 2011
PMID: 21219704Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Propylhexedrine (substance)
SNOMED CT
51321007
UMLS CUI
C0033508
RxNorm CUI
8792

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.